{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T06:09:03Z","timestamp":1774418943720,"version":"3.50.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["FCT-2024.01355.BD"],"award-info":[{"award-number":["FCT-2024.01355.BD"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-025-02744-9","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T06:35:48Z","timestamp":1762756548000},"page":"621-634","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic complications in a large cohort of Portuguese women with hirsutism-related disorders"],"prefix":"10.1007","volume":"49","author":[{"given":"Joana","family":"Pinto","sequence":"first","affiliation":[]},{"given":"Nicoletta","family":"Cera","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5555-7004","authenticated-orcid":false,"given":"Duarte","family":"Pignatelli","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"issue":"5","key":"2744_CR1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ogrm.2018.03.004","volume":"28","author":"S Kini","year":"2018","unstructured":"Kini S, Ramalingam M, Obstetrics (2018) Gynecol Reproductive Med 28(5):129\u2013135. https:\/\/doi.org\/10.1016\/j.ogrm.2018.03.004","journal-title":"Gynecol Reproductive Med"},{"key":"2744_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-024-01057-w","author":"N Helvaci","year":"2024","unstructured":"Helvaci N, Yildiz BO (2024) Polycystic ovary syndrome as a metabolic disease. Nat Rev Endocrinol. https:\/\/doi.org\/10.1038\/s41574-024-01057-w","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"2744_CR3","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.fertnstert.2010.12.027","volume":"95","author":"RA Wild","year":"2011","unstructured":"Wild RA, Rizzo M, Clifton S, Carmina E (2011) Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril 95(3):1073-9e11. https:\/\/doi.org\/10.1016\/j.fertnstert.2010.12.027","journal-title":"Fertil Steril"},{"issue":"5","key":"2744_CR4","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrendo.2018.24","volume":"14","author":"HF Escobar-Morreale","year":"2018","unstructured":"Escobar-Morreale HF (2018) Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol 14(5):270\u2013284. https:\/\/doi.org\/10.1038\/nrendo.2018.24","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"2744_CR5","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.fertnstert.2009.06.025","volume":"94","author":"M Pall","year":"2010","unstructured":"Pall M, Azziz R, Beires J, Pignatelli D (2010) The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia. Fertil Steril 94(2):684\u2013689. https:\/\/doi.org\/10.1016\/j.fertnstert.2009.06.025","journal-title":"Fertil Steril"},{"issue":"3","key":"2744_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14030673","volume":"14","author":"J Pinto","year":"2025","unstructured":"Pinto J, Cera N, Camerino C, Beires J, Pignatelli D (2025) Androgens and hirsutism in a large cohort of Portuguese women. J Clin Med 14(3):673. https:\/\/doi.org\/10.3390\/jcm14030673","journal-title":"J Clin Med"},{"issue":"6","key":"2744_CR7","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1159\/000086363","volume":"63","author":"F Saygili","year":"2005","unstructured":"Saygili F, Oge A, Yilmaz C (2005) Hyperinsulinemia and insulin insensitivity in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: the relationship between serum leptin levels and chronic hyperinsulinemia. Horm Res 63(6):270\u2013274. https:\/\/doi.org\/10.1159\/000086363","journal-title":"Horm Res"},{"issue":"5","key":"2744_CR8","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/MAJ.0b013e31824369e4","volume":"344","author":"MF Mnif","year":"2012","unstructured":"Mnif MF, Kamoun M, Mnif F, Charfi N, Kallel N, Ben Naceur B, Rekik N, Mnif Z, Sfar MH, Sfar MT et al (2012) Long-term outcome of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Am J Med Sci 344(5):363\u2013373. https:\/\/doi.org\/10.1097\/MAJ.0b013e31824369e4","journal-title":"Am J Med Sci"},{"issue":"1","key":"2744_CR9","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s12020-015-0656-0","volume":"50","author":"H Falhammar","year":"2015","unstructured":"Falhammar H, Nordenstr\u00f6m A (2015) Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome. Endocrine 50(1):32\u201350. https:\/\/doi.org\/10.1007\/s12020-015-0656-0","journal-title":"Endocrine"},{"issue":"11","key":"2744_CR10","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.1210\/jc.2010-0917","volume":"95","author":"W Arlt","year":"2010","unstructured":"Arlt W, Willis DS, Wild SH, Krone N, Doherty EJ, Hahner S, Han TS, Carroll PV, Conway GS, Rees DA et al (2010) Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients. J Clin Endocrinol Metab 95(11):5110\u20135121. https:\/\/doi.org\/10.1210\/jc.2010-0917","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2744_CR11","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1210\/JC.2015-2093","volume":"100","author":"H Falhammar","year":"2015","unstructured":"Falhammar H, Fris\u00e9n L, Hirschberg AL, Norrby C, Almqvist C, Nordenskj\u00f6ld A, Nordenstr\u00f6m A (2015) Increased cardiovascular and metabolic morbidity in patients with 21-Hydroxylase deficiency: a Swedish population-based national cohort study. J Clin Endocrinol Metab 100(9):3520\u20133528. https:\/\/doi.org\/10.1210\/JC.2015-2093","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2744_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.hlc.2020.05.108","volume":"30","author":"L Geraghty","year":"2021","unstructured":"Geraghty L, Figtree GA, Schutte AE, Patel S, Woodward M, Arnott C (2021) Cardiovascular disease in women: from pathophysiology to novel and emerging risk factors. Heart Lung Circ 30(1):9\u201317. https:\/\/doi.org\/10.1016\/j.hlc.2020.05.108","journal-title":"Heart Lung Circ"},{"issue":"11","key":"2744_CR13","doi-asserted-by":"publisher","first-page":"5346","DOI":"10.1111\/jocd.15070","volume":"21","author":"M Amiri","year":"2022","unstructured":"Amiri M, Mahmoudieh L, Sheidaei A, Fallahzadeh A, Ramezani Tehrani F (2022) Insulin resistance and idiopathic hirsutism: a systematic review, meta-analysis, and meta\u2010regression. J Cosmet Dermatol 21(11):5346\u20135359. https:\/\/doi.org\/10.1111\/jocd.15070","journal-title":"J Cosmet Dermatol"},{"issue":"5","key":"2744_CR14","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1210\/jc.2004-2279","volume":"90","author":"E Carmina","year":"2005","unstructured":"Carmina E, Chu MC, Longo RA, Rini GB, Lobo RA (2005) Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters. J Clin Endocrinol Metab 90(5):2545\u20132549. https:\/\/doi.org\/10.1210\/jc.2004-2279","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2744_CR15","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1530\/eje.1.02212","volume":"155","author":"H Atmaca","year":"2006","unstructured":"Atmaca H, Tanriverdi F, Unluhizarci K, Bayram F, Kelestimur F (2006) Investigation of adrenal functions in patients with idiopathic hyperandrogenemia. Eur J Endocrinol 155(2):307\u2013311. https:\/\/doi.org\/10.1530\/eje.1.02212","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2744_CR16","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/j.fertnstert.2006.02.069","volume":"85","author":"E Carmina","year":"2006","unstructured":"Carmina E (2006) The spectrum of androgen excess disorders. Fertil Steril 85(6):1582\u20131585. https:\/\/doi.org\/10.1016\/j.fertnstert.2006.02.069","journal-title":"Fertil Steril"},{"key":"2744_CR17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/03610929108830487","volume":"20","author":"CE Douglas","year":"1991","unstructured":"Douglas CE, Michael FA (1991) On distribution-free multiple comparisons in the one-way analysis of variance. Commun Stat 20:127\u2013139","journal-title":"Commun Stat"},{"key":"2744_CR18","doi-asserted-by":"publisher","unstructured":"Sheskin DJ (2003) Handbook of parametric and nonparametric statistical procedures. Chapman and hall\/CRC. https:\/\/doi.org\/10.1201\/9781420036268","DOI":"10.1201\/9781420036268"},{"issue":"1","key":"2744_CR19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1210\/jc.2005-1457","volume":"91","author":"E Carmina","year":"2006","unstructured":"Carmina E, Rosato F, Janni A, Rizzo M, Longo RA (2006) Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab 91(1):2\u20136. https:\/\/doi.org\/10.1210\/jc.2005-1457","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2744_CR20","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1093\/humupd\/dms030","volume":"18","author":"SS Lim","year":"2012","unstructured":"Lim SS, Davies MJ, Norman RJ, Moran LJ (2012) Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 18(6):618\u2013637. https:\/\/doi.org\/10.1093\/humupd\/dms030","journal-title":"Hum Reprod Update"},{"issue":"3","key":"2744_CR21","doi-asserted-by":"publisher","first-page":"e899","DOI":"10.1210\/clinem\/dgab757","volume":"107","author":"T Zhu","year":"2022","unstructured":"Zhu T, Goodarzi MO (2022) Causes and consequences of polycystic ovary syndrome: insights from Mendelian randomization. J Clin Endocrinol Metab 107(3):e899\u2013e911. https:\/\/doi.org\/10.1210\/clinem\/dgab757","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2744_CR22","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1093\/humrep\/des232","volume":"27","author":"BO Yildiz","year":"2012","unstructured":"Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H (2012) Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod 27(10):3067\u20133073. https:\/\/doi.org\/10.1093\/humrep\/des232","journal-title":"Hum Reprod"},{"issue":"4","key":"2744_CR23","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1093\/humupd\/dmx012","volume":"23","author":"HF Escobar-Morreale","year":"2017","unstructured":"Escobar-Morreale HF, Santacruz E, Luque-Ram\u00edrez M, Botella Carretero JI (2017) Prevalence of \u2018obesity-associated gonadal dysfunction\u2019 in severely obese men and women and its resolution after bariatric surgery: a systematic review and meta-analysis. Hum Reprod Update 23(4):390\u2013408. https:\/\/doi.org\/10.1093\/humupd\/dmx012","journal-title":"Hum Reprod Update"},{"issue":"10","key":"2744_CR24","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1111\/j.1471-0528.2006.00990.x","volume":"113","author":"R Pasquali","year":"2006","unstructured":"Pasquali R, Gambineri A, Pagotto U (2006) The impact of obesity on reproduction in women with polycystic ovary syndrome. BJOG 113(10):1148\u20131159. https:\/\/doi.org\/10.1111\/j.1471-0528.2006.00990.x","journal-title":"BJOG"},{"key":"2744_CR25","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1159\/000342179","volume":"40","author":"D Pignatelli","year":"2013","unstructured":"Pignatelli D (2013) Non-classic adrenal hyperplasia due to the deficiency of 21-hydroxylase and its relation to polycystic ovarian syndrome. Front Horm Res 40:158\u2013170. https:\/\/doi.org\/10.1159\/000342179","journal-title":"Front Horm Res"},{"key":"2744_CR26","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fendo.2019.00388","volume":"10","author":"G Papadakis","year":"2019","unstructured":"Papadakis G, Kandaraki EA, Tseniklidi E, Papalou O, Diamanti-Kandarakis E (2019) Polycystic ovary syndrome and NC-CAH: distinct characteristics and common findings. Syst Rev Front Endocrinol (Lausanne) 10:388. https:\/\/doi.org\/10.3389\/fendo.2019.00388","journal-title":"Syst Rev Front Endocrinol (Lausanne)"},{"issue":"3","key":"2744_CR27","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1080\/09513590801911992","volume":"24","author":"M Fanta","year":"2008","unstructured":"Fanta M, Cibula D, Vrb\u00edkov\u00e1 J (2008) Prevalence of nonclassic adrenal hyperplasia (NCAH) in hyperandrogenic women. Gynecol Endocrinol 24(3):154\u2013157. https:\/\/doi.org\/10.1080\/09513590801911992","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"2744_CR28","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1210\/jcem.78.4.8157702","volume":"78","author":"R Azziz","year":"1994","unstructured":"Azziz R, Dewailly D, Owerbach D (1994) Clinical review 56: nonclassic adrenal hyperplasia: current concepts. J Clin Endocrinol Metab 78(4):810\u2013815. https:\/\/doi.org\/10.1210\/jcem.78.4.8157702","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2744_CR29","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1210\/clinem\/dgae155","volume":"110","author":"FC Costa","year":"2024","unstructured":"Costa FC, Gomes LG, de Lima TM, Bortolotto LA, Hong V, Verardino R, de Souza Rocha M, Ueda SKN, de Miranda MC, de Souza HP et al (2024) Cardiovascular risk in women with nonclassical congenital adrenal hyperplasia. J Clin Endocrinol Metab 110(1):e72\u2013e79. https:\/\/doi.org\/10.1210\/clinem\/dgae155","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2744_CR30","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1210\/jc.2007-1834","volume":"93","author":"BO Yildiz","year":"2008","unstructured":"Yildiz BO, Knochenhauer ES, Azziz R (2008) Impact of obesity on the risk for polycystic ovary syndrome. J Clin Endocrinol Metab 93(1):162\u2013168. https:\/\/doi.org\/10.1210\/jc.2007-1834","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2744_CR31","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1210\/clinem\/dgaa125","volume":"105","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Xu Y, Wang X, Xu L, Chen J, Gao C, Wu C, Pan D, Zhang Q, Zhou J et al (2020) Body mass index and polycystic ovary syndrome: a 2-sample bidirectional Mendelian randomization study. J Clin Endocrinol Metab 105(6):1778\u20131784. https:\/\/doi.org\/10.1210\/clinem\/dgaa125","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2744_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02238-y","volume":"20","author":"Q Liu","year":"2022","unstructured":"Liu Q, Zhu Z, Kraft P, Deng Q, Stener-Victorin E, Jiang X (2022) Genomic correlation, shared loci, and causal relationship between obesity and polycystic ovary syndrome: a large-scale genome-wide cross-trait analysis. BMC Med 20(1):66. https:\/\/doi.org\/10.1186\/s12916-022-02238-y","journal-title":"BMC Med"},{"issue":"6","key":"2744_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2024.103849","volume":"48","author":"L Zhang","year":"2024","unstructured":"Zhang L, Feng Y, Sun X, Yi S, Xiao X, Ma F (2024) Impact of body mass index on assisted reproductive technology outcomes in patients with polycystic ovary syndrome: a meta-analysis. Reprod Biomed Online 48(6):103849. https:\/\/doi.org\/10.1016\/j.rbmo.2024.103849","journal-title":"Reprod Biomed Online"},{"issue":"5","key":"2744_CR34","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1210\/er.2015-1104","volume":"37","author":"RL Rosenfield","year":"2016","unstructured":"Rosenfield RL, Ehrmann DA (2016) The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev 37(5):467\u2013520. https:\/\/doi.org\/10.1210\/er.2015-1104","journal-title":"Endocr Rev"},{"issue":"11","key":"2744_CR35","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1093\/humrep\/dew243","volume":"31","author":"S Cassar","year":"2016","unstructured":"Cassar S, Misso ML, Hopkins WG, Shaw CS, Teede HJ, Stepto NK (2016) Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies. Hum Reprod 31(11):2619\u20132631. https:\/\/doi.org\/10.1093\/humrep\/dew243","journal-title":"Hum Reprod"},{"key":"2744_CR36","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.metabol.2018.11.002","volume":"92","author":"CJ Glueck","year":"2019","unstructured":"Glueck CJ, Goldenberg N (2019) Characteristics of obesity in polycystic ovary syndrome: etiology, treatment, and genetics. Metabolism 92:108\u2013120. https:\/\/doi.org\/10.1016\/j.metabol.2018.11.002","journal-title":"Metabolism"},{"issue":"8","key":"2744_CR37","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1080\/00015385.2019.1666964","volume":"75","author":"R Krysiak","year":"2020","unstructured":"Krysiak R, Kowalcze K, Marek B, Okopie\u0144 B (2020) Cardiometabolic risk factors in women with non-classic congenital adrenal hyperplasia. Acta Cardiol 75(8):705\u2013710. https:\/\/doi.org\/10.1080\/00015385.2019.1666964","journal-title":"Acta Cardiol"},{"issue":"4","key":"2744_CR38","doi-asserted-by":"publisher","first-page":"E628","DOI":"10.1210\/jc.2012-3908","volume":"98","author":"P Moghetti","year":"2013","unstructured":"Moghetti P, Tosi F, Bonin C, Di Sarra D, Fiers T, Kaufman JM, Giagulli VA, Signori C, Zambotti F, Dall\u2019Alda M, Spiazzi G, Zanolin ME, Bonora E (2013) Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome. J Clin Endocrinol Metab 98(4):E628\u2013637. https:\/\/doi.org\/10.1210\/jc.2012-3908","journal-title":"J Clin Endocrinol Metab"},{"key":"2744_CR39","doi-asserted-by":"publisher","DOI":"10.1177\/1179558119874042","volume":"13","author":"TM Barber","year":"2019","unstructured":"Barber TM, Hanson P, Weickert MO, Franks S (2019) Obesity and polycystic ovary syndrome: implications for pathogenesis and novel management strategies. Clin Med Insights Reprod Health 13:1179558119874042. https:\/\/doi.org\/10.1177\/1179558119874042","journal-title":"Clin Med Insights Reprod Health"},{"issue":"12","key":"2744_CR40","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1093\/humrep\/dex308","volume":"32","author":"F Tosi","year":"2017","unstructured":"Tosi F, Bonora E, Moghetti P (2017) Insulin resistance in a large cohort of women with polycystic ovary syndrome: a comparison between euglycaemic-hyperinsulinaemic clamp and surrogate indexes. Hum Reprod 32(12):2515\u20132521. https:\/\/doi.org\/10.1093\/humrep\/dex308","journal-title":"Hum Reprod"},{"issue":"3","key":"2744_CR41","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.fertnstert.2004.01.041","volume":"82","author":"E Carmina","year":"2004","unstructured":"Carmina E, Lobo RA (2004) Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome. Fertil Steril 82(3):661\u2013665. https:\/\/doi.org\/10.1016\/j.fertnstert.2004.01.041","journal-title":"Fertil Steril"},{"issue":"3","key":"2744_CR42","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4239\/wjd.v13.i3.129","volume":"13","author":"CA Amisi","year":"2022","unstructured":"Amisi CA (2022) Markers of insulin resistance in polycystic ovary syndrome women: an update. World J Diabetes 13(3):129\u2013149. https:\/\/doi.org\/10.4239\/wjd.v13.i3.129","journal-title":"World J Diabetes"},{"issue":"10","key":"2744_CR43","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1210\/jcem.86.10.7952","volume":"86","author":"MJ Quon","year":"2001","unstructured":"Quon MJ (2001) Limitations of the fasting glucose to insulin ratio as an index of insulin sensitivity. J Clin Endocrinol Metab 86(10):4615\u20134617. https:\/\/doi.org\/10.1210\/jcem.86.10.7952","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2744_CR44","doi-asserted-by":"publisher","first-page":"47","DOI":"10.4158\/EP09031.OR","volume":"16","author":"JL Johnson","year":"2010","unstructured":"Johnson JL, Duick DS, Chui MA, Aldasouqi SA (2010) Identifying prediabetes using fasting insulin levels. Endocr Pract 16(1):47\u201352. https:\/\/doi.org\/10.4158\/EP09031.OR","journal-title":"Endocr Pract"},{"issue":"6","key":"2744_CR45","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3109\/09513590.2013.774362","volume":"29","author":"F Lunger","year":"2013","unstructured":"Lunger F, Wildt L, Seeber B (2013) Accurate screening for insulin resistance in PCOS women using fasting insulin concentrations. Gynecol Endocrinol 29(6):541\u2013544. https:\/\/doi.org\/10.3109\/09513590.2013.774362","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"2744_CR46","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1210\/jc.2018-01771","volume":"104","author":"SL Hansen","year":"2019","unstructured":"Hansen SL, Svendsen PF, Jeppesen JF, Hoeg LD, Andersen NR, Kristensen JM, Nilas L, Lundsgaard AM, Wojtaszewski JFP, Madsbad S, Kiens B (2019) Molecular mechanisms in skeletal muscle underlying insulin resistance in women who are lean with polycystic ovary syndrome. J Clin Endocrinol Metab 104(5):1841\u20131854. https:\/\/doi.org\/10.1210\/jc.2018-01771","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2744_CR47","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s40618-020-01351-0","volume":"44","author":"P Moghetti","year":"2021","unstructured":"Moghetti P, Tosi F (2021) Insulin resistance and PCOS: chicken or egg? J Endocrinol Invest 44(2):233\u2013244. https:\/\/doi.org\/10.1007\/s40618-020-01351-0","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"2744_CR48","doi-asserted-by":"publisher","first-page":"616","DOI":"10.4239\/wjd.v12.i5.616","volume":"12","author":"K Unluhizarci","year":"2021","unstructured":"Unluhizarci K, Karaca Z, Kelestimur F (2021) Role of insulin and insulin resistance in androgen excess disorders. World J Diabetes 12(5):616\u2013629. https:\/\/doi.org\/10.4239\/wjd.v12.i5.616","journal-title":"World J Diabetes"},{"issue":"1\u20132","key":"2744_CR49","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/s0303-7207(99)00203-8","volume":"159","author":"N Sekar","year":"2000","unstructured":"Sekar N, Garmey JC, Veldhuis JD (2000) Mechanisms underlying the steroidogenic synergy of insulin and luteinizing hormone in porcine granulosa cells: joint amplification of pivotal sterol-regulatory genes encoding the low-density lipoprotein (LDL) receptor, steroidogenic acute regulatory (stAR) protein and cytochrome P450 side-chain cleavage (P450scc) enzyme. Mol Cell Endocrinol 159(1\u20132):25\u201335. https:\/\/doi.org\/10.1016\/s0303-7207(99)00203-8","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"2744_CR50","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/humrep\/deh609","volume":"20","author":"S Rice","year":"2005","unstructured":"Rice S, Christoforidis N, Gadd C, Nikolaou D, Seyani L, Donaldson A, Margara R, Hardy K, Franks S (2005) Impaired insulin-dependent glucose metabolism in granulosa-lutein cells from anovulatory women with polycystic ovaries. Hum Reprod 20(2):373\u2013381. https:\/\/doi.org\/10.1093\/humrep\/deh609","journal-title":"Hum Reprod"},{"issue":"5","key":"2744_CR51","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1111\/jocd.15608","volume":"22","author":"M Amiri","year":"2023","unstructured":"Amiri M, Mahmoudieh L, Sheidaei A, Ramezani Tehrani F (2023) Idiopathic hirsutism and dyslipidemia: a systematic review, meta-analysis, and meta\u2010regressions. J Cosmet Dermatol 22(5):1449\u20131462. https:\/\/doi.org\/10.1111\/jocd.15608","journal-title":"J Cosmet Dermatol"},{"issue":"2","key":"2744_CR52","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s40618-014-0164-8","volume":"38","author":"F Ramezani Tehrani","year":"2015","unstructured":"Ramezani Tehrani F, Behboudi-Gandevani S, Simbar M, Azizi F (2015) A population-based study of the relationship between idiopathic hirsutism and metabolic disturbances. J Endocrinol Invest 38(2):155\u2013162. https:\/\/doi.org\/10.1007\/s40618-014-0164-8","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"2744_CR53","doi-asserted-by":"publisher","first-page":"177","DOI":"10.5114\/ada.2019.84593","volume":"36","author":"IH Yavuz","year":"2019","unstructured":"Yavuz IH, Ozaydin-Yavuz G, \u00c7okluk E, Kurto\u011flu Z, Bilgili SG (2019) Investigation of galectin-3, lipocalin 2, retinol binding protein (RBP), small dense low-density lipoprotein (sdLDL) in patients with hirsutism. Adv Dermatol Allergol 36(2):177\u2013183. https:\/\/doi.org\/10.5114\/ada.2019.84593","journal-title":"Adv Dermatol Allergol"},{"key":"2744_CR54","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/593197","volume":"2013","author":"A Talaei","year":"2013","unstructured":"Talaei A, Adgi Z, Mohamadi Kelishadi M (2013) Idiopathic hirsutism and insulin resistance. Int J Endocrinol 2013:593197. https:\/\/doi.org\/10.1155\/2013\/593197","journal-title":"Int J Endocrinol"},{"issue":"3","key":"2744_CR55","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1159\/000096434","volume":"63","author":"F Sarac","year":"2007","unstructured":"Sarac F, Saygili F, Ozgen G, Tuzun M, Yilmaz C, Kabalak T (2007) Assessment of insulin resistance in the idiopathic hirsutism. Gynecol Obstet Invest 63(3):126\u2013131. https:\/\/doi.org\/10.1159\/000096434","journal-title":"Gynecol Obstet Invest"},{"issue":"4","key":"2744_CR56","doi-asserted-by":"publisher","first-page":"340","DOI":"10.23736\/S0391-1977.17.02609-8","volume":"42","author":"G Papadakis","year":"2017","unstructured":"Papadakis G, Kandaraki E, Papalou O, Vryonidou A, Diamanti-Kandarakis E (2017) Is cardiovascular risk in women with PCOS a real risk? Current insights. Minerva Endocrinol 42(4):340\u2013355. https:\/\/doi.org\/10.23736\/S0391-1977.17.02609-8","journal-title":"Minerva Endocrinol"},{"issue":"8","key":"2744_CR57","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/s0002-9343(01)00948-2","volume":"111","author":"RS Legro","year":"2001","unstructured":"Legro RS, Kunselman AR, Dunaif A (2001) Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med 111(8):607\u2013613. https:\/\/doi.org\/10.1016\/s0002-9343(01)00948-2","journal-title":"Am J Med"},{"issue":"5","key":"2744_CR58","doi-asserted-by":"publisher","first-page":"E841","DOI":"10.1210\/jc.2013-3918","volume":"99","author":"A Roe","year":"2014","unstructured":"Roe A, Hillman J, Butts S, Smith M, Rader D, Playford M, Mehta NN, Dokras A (2014) Decreased cholesterol efflux capacity and atherogenic lipid profile in young women with PCOS. J Clin Endocrinol Metab 99(5):E841\u2013E847. https:\/\/doi.org\/10.1210\/jc.2013-3918","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2744_CR59","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/cen.14155","volume":"92","author":"PT Kotecha","year":"2020","unstructured":"Kotecha PT, Godsland IF, Crook D, Stevenson JC (2020) Effects of tibolone or continuous combined oestradiol and norethisterone acetate on lipids, high-density lipoprotein subfractions and apolipoproteins in postmenopausal women in a two-year, randomized, double-blind, placebo-controlled trial. Clin Endocrinol (Oxf) 92(4):303\u2013311. https:\/\/doi.org\/10.1111\/cen.14155","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2744_CR60","doi-asserted-by":"publisher","first-page":"627","DOI":"10.2337\/db20-0800","volume":"70","author":"T Zhu","year":"2021","unstructured":"Zhu T, Cui J, Goodarzi MO (2021) Polycystic ovary syndrome and risk of type 2 diabetes, coronary heart disease, stroke. Diabetes 70(2):627\u2013637. https:\/\/doi.org\/10.2337\/db20-0800","journal-title":"Diabetes"},{"issue":"3","key":"2744_CR61","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/ejendo\/lvaf027","volume":"192","author":"A Gambineri","year":"2025","unstructured":"Gambineri A, Rosa S, Pandurevic S, Cecchetti C, Rotolo L, Dionese P, Belardinelli E, Solmi B, Zavatta G, Fanelli F et al (2025) Evolution of cardiovascular risk factors and the risk for cardiovascular events in a Caucasian population with polycystic ovary syndrome. Eur J Endocrinol 192(3):210\u2013219. https:\/\/doi.org\/10.1093\/ejendo\/lvaf027","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2744_CR62","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1210\/clinem\/dgab613","volume":"107","author":"C Riestenberg","year":"2022","unstructured":"Riestenberg C, Jagasia A, Markovic D, Buyalos RP, Azziz R (2022) Health care-related economic burden of polycystic ovary syndrome in the United States: pregnancy-related and long-term health consequences. J Clin Endocrinol Metab 107(2):575\u2013585. https:\/\/doi.org\/10.1210\/clinem\/dgab613","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2744_CR63","doi-asserted-by":"publisher","first-page":"4874","DOI":"10.1210\/jc.2010-2167","volume":"95","author":"TA Buchanan","year":"2010","unstructured":"Buchanan TA, Watanabe RM, Xiang AH (2010) Limitations in surrogate measures of insulin resistance. J Clin Endocrinol Metab 95(11):4874\u20134876. https:\/\/doi.org\/10.1210\/jc.2010-2167","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02744-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-025-02744-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02744-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T05:17:51Z","timestamp":1774415871000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-025-02744-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":63,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["2744"],"URL":"https:\/\/doi.org\/10.1007\/s40618-025-02744-9","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"28 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"D.P. is a member of the editorial board of the\n                      Journal of Endocrinological Investigation\n                      .","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of CHUSJ (Prot.n.23000471 and date of approval 2023.01.10).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}